Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Non-Current Debt (2020)

Historic Non-Current Debt for Vistagen Therapeutics (VTGN) over the last 3 years, with Q3 2020 value amounting to $87300.0.

  • Vistagen Therapeutics' Non-Current Debt changed N/A to $87300.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $87300.0, marking a year-over-year change of. This contributed to the annual value of $500.0 for FY2011, which is N/A changed from last year.
  • As of Q3 2020, Vistagen Therapeutics' Non-Current Debt stood at $87300.0.
  • Over the past 5 years, Vistagen Therapeutics' Non-Current Debt peaked at $124700.0 during Q2 2020, and registered a low of $87300.0 during Q3 2020.